Multi-drug resistant Acinetobacter ventilator-associated pneumonia
Open Access
- 1 January 2010
- journal article
- research article
- Published by Medknow in Lung India
- Vol. 27 (4), 217-220
- https://doi.org/10.4103/0970-2113.71952
Abstract
Background: Ventilator-associated pneumonia (VAP) due to a multi-drug resistant (MDR) Acinetobacter is one of the most dreadful complications, which occurs in the critical care setting. Aims and objectives: To find out the incidence of Acinetobacter infection in VAP cases, to determine various risk factors responsible for acquisition of Acinetobacter infection and to determine the antimicrobial susceptibility pattern of Acinetobacter. Materials and Methods: A total of 60 endotracheal aspirate specimens from intubated patients diagnosed clinically and microscopically as VAP were studied bacteriologically. All clinical details and prior exposure to antibiotics were recorded. Results: An incidence of 11.6% of Acinetobacter VAP cases was recorded. Various underlying conditions like head injury, cerebral hemorrhage and chronic obstructive pulmonary disease (COPD) were found to be associated with Acinetobacter VAP. Acinetobacter strains exhibited MDR pattern. Conclusion: Strict infection control measures, judicious prescribing of antibiotics, antibiotic resistance surveillance programs and antibiotic cycling should be adopted to control infections due to these bacteria in patients admitted to intensive care units.Keywords
This publication has 18 references indexed in Scilit:
- The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter SpeciesClinical Infectious Diseases, 2006
- Acinetobacter parvus sp. nov., a small-colony-forming species isolated from human clinical specimensInternational Journal of Systematic and Evolutionary Microbiology, 2003
- Treatment of Multidrug‐ResistantAcinetobacter baumanniiVentilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAPClinical Infectious Diseases, 2003
- Comparison of Ampicillin‐Sulbactam and Imipenem‐Cilastatin for the Treatment ofAcinetobacterVentilator‐Associated PneumoniaClinical Infectious Diseases, 2002
- Clinical signs and scores for the diagnosis of ventilator-associated pneumonia.2002
- Endemic Carbapenem-Resistant Acinetobacter Species in Brooklyn, New York: Citywide Prevalence, Interinstitutional Spread, and Relation to Antibiotic UsageClinical Infectious Diseases, 2000
- Ventilator-associated Pneumonia Caused by Potentially Drug-resistant BacteriaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Risk Factors for Infection by Acinetobacter baumannii in Intubated Patients With Nosocomial PneumoniaSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1997
- Phylogenetic Relationship of the Twenty-One DNA Groups of the Genus Acinetobacter as Revealed by 16S Ribosomal DNA Sequence AnalysisInternational Journal of Systematic and Evolutionary Microbiology, 1997
- Nosocomial Acquisition of Multiresistant Acinetobacter baumannii: Risk Factors and PrognosisClinical Infectious Diseases, 1995